{"id":471493,"date":"2021-04-06T07:48:22","date_gmt":"2021-04-06T11:48:22","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=471493"},"modified":"2021-04-06T07:48:22","modified_gmt":"2021-04-06T11:48:22","slug":"lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\/","title":{"rendered":"Lantern Pharma to Participate in the Virtual 20th Annual Needham Healthcare Conference"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">DALLAS<\/span>, <span class=\"xn-chron\">April 6, 2021<\/span> \/PRNewswire\/ &#8212;\u00a0<b>Lantern Pharma Inc. (NASDAQ: LTRN)<\/b>, a clinical stage biopharmaceutical company using its proprietary <i>RADR<\/i><sup>\u00ae<\/sup> artificial intelligence (&#8220;A.I.&#8221;) platform to transform oncology drug discovery and development today announced that <span class=\"xn-person\">Panna Sharma<\/span>, President and CEO of Lantern Pharma, will participate in the 20<sup>th<\/sup> Annual Needham Healthcare Conference, to be held virtually on <span class=\"xn-chron\">April 12-15, 2021<\/span>.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1216507\/Lantern_Pharma_Logo.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1216507\/Lantern_Pharma_Logo.jpg\" title=\"Lantern Pharma (LTRN) Logo (PRNewsfoto\/Lantern Pharma)\" alt=\"Lantern Pharma (LTRN) Logo (PRNewsfoto\/Lantern Pharma)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>Mr. Sharma will participate in a fireside chat moderated by Needham &amp; Company&#8217;s <span class=\"xn-person\">Alexander Salisbury<\/span> on <span class=\"xn-chron\">Thursday, April 15<\/span>, at <span class=\"xn-chron\">12:45 pm ET<\/span> and hold one-on-one meetings with investors throughout the four-day event.<\/p>\n<p>The live event will be accessible on <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3119950-1&amp;h=1493796031&amp;u=https%3A%2F%2Fir.lanternpharma.com%2F&amp;a=https%3A%2F%2Fir.lanternpharma.com\" rel=\"nofollow noopener noreferrer\">https:\/\/ir.lanternpharma.com<\/a>\u00a0and will be archived for 90 days. Investors interested in scheduling a meeting with Mr. Sharma should contact their Needham &amp; Company representative or Lantern Pharma investor relations.<\/p>\n<p>\n        <b>Contact<br \/><\/b><br \/>\n        <span class=\"xn-person\">Marek Ciszewski<\/span>, JD<br \/>Director, Investor Relations<br \/>628-777-3167<br \/><a target=\"_blank\" href=\"mailto:ir@lanternpharma.com\" rel=\"nofollow noopener noreferrer\">ir@lanternpharma.com<\/a><\/p>\n<p>\n        <b>About Lantern Pharma<br \/><\/b>Lantern Pharma (LTRN) is a clinical-stage biopharmaceutical company leveraging its proprietary RADR<sup>\u00ae <\/sup>A.I. platform and machine learning to discover biomarker signatures that identify patients most likely to respond to its pipeline of genomically-targeted cancer therapeutics. We believe our RADR\u00ae A.I. platform is among the world&#8217;s largest A.I. oncology datasets. Once a drug candidate is identified and validated with the assistance of RADR<sup>\u00ae <\/sup>A.I., Lantern seeks out industry partners, collaborators and leading scientific advisors to develop genetically-targeted cancer therapeutics in areas of high unmet clinical need. Lantern is currently developing four drug candidates and an ADC program, including two phase 2 programs. By targeting drugs to patients whose genomic profile identifies them as having the highest probability of benefiting from the drug, Lantern&#8217;s approach represents the potential to deliver best-in-class outcomes. More information is available at:\u00a0www.lanternpharma.com\u00a0and Twitter<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3119950-1&amp;h=1746483693&amp;u=https%3A%2F%2Ftwitter.com%2Flanternpharma&amp;a=%C2%A0%40lanternpharma\" rel=\"nofollow noopener noreferrer\">\u00a0@lanternpharma<\/a>.<\/p>\n<p>\n        <b>Forward-looking Statements<br \/><\/b>This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, among other things, statements relating to: future events or our future financial performance; the potential advantages of our RADR<sup>\u00ae<\/sup>\u00a0platform in identifying drug candidates and patient populations that are likely to respond to a drug candidate; our strategic plans to advance the development of our drug candidates and antibody drug conjugate (ADC) development program; estimates regarding the development timing for our drug candidates and ADC development program; our research and development efforts of our internal drug discovery programs and the utilization of our RADR<sup>\u00ae<\/sup>\u00a0platform to streamline the drug development process; our intention to leverage artificial intelligence, machine learning and genomic data to streamline and transform the pace, risk and cost of oncology drug discovery and development and to identify patient populations that would likely respond to a drug candidate; estimates regarding potential markets and potential market sizes; sales estimates for our drug candidates and our plans to discover and develop drug candidates and to maximize their commercial potential by advancing such drug candidates ourselves or in collaboration with others. Any statements that are not statements of historical fact (including, without limitation, statements that use words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;contemplate,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;seek,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;target,&#8221; &#8220;aim,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; or the negative of these words or other similar expressions) should be considered forward-looking statements. There are a number of important factors that could cause our actual results to differ materially from those indicated by the forward-looking statements, such as (i) the impact of the COVID-19 pandemic, (ii) the risk that none of our product candidates has received FDA marketing approval, and we may not be able to successfully initiate, conduct, or conclude clinical testing for or obtain marketing approval for our product candidates; (iii) the risk that no drug product based on our proprietary RADR A.I. platform has received FDA marketing approval or otherwise been incorporated into a commercial product, and (iv) those other factors set forth in the Risk Factors section in our Annual Report on Form 10-K for the year ended <span class=\"xn-chron\">December 31, 2020<\/span>, filed with the Securities and Exchange Commission on <span class=\"xn-chron\">March 10, 2021<\/span>. You may access our Annual Report on Form 10-K for the year ended <span class=\"xn-chron\">December 31, 2020<\/span> under the investor SEC filings tab of our website at<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3119950-1&amp;h=3070111085&amp;u=http%3A%2F%2Fwww.lanternpharma.com%2F&amp;a=%C2%A0www.lanternpharma.com\" rel=\"nofollow noopener noreferrer\">\u00a0www.lanternpharma.com<\/a> or on the SEC&#8217;s website at<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3119950-1&amp;h=2209851659&amp;u=http%3A%2F%2Fwww.sec.gov%2F&amp;a=%C2%A0www.sec.gov\" rel=\"nofollow noopener noreferrer\">\u00a0www.sec.gov<\/a>. Given these risks and uncertainties, we can give no assurances that our forward-looking statements will prove to be accurate, or that any other results or events projected or contemplated by our forward-looking statements will in fact occur, and we caution investors not to place undue reliance on these statements. All forward-looking statements in this press release represent our judgment as of the date hereof, and, except as otherwise required by law, we disclaim any obligation to update any forward-looking statements to conform the statement to actual results or changes in our expectations.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=DA33331&amp;sd=2021-04-06\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference-301262929.html\">http:\/\/www.prnewswire.com\/news-releases\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference-301262929.html<\/a><\/p>\n<p>SOURCE  Lantern Pharma<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=DA33331&amp;Transmission_Id=202104060745PR_NEWS_USPR_____DA33331&amp;DateId=20210406\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire DALLAS, April 6, 2021 \/PRNewswire\/ &#8212;\u00a0Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR\u00ae artificial intelligence (&#8220;A.I.&#8221;) platform to transform oncology drug discovery and development today announced that Panna Sharma, President and CEO of Lantern Pharma, will participate in the 20th Annual Needham Healthcare Conference, to be held virtually on April 12-15, 2021. Mr. Sharma will participate in a fireside chat moderated by Needham &amp; Company&#8217;s Alexander Salisbury on Thursday, April 15, at 12:45 pm ET and hold one-on-one meetings with investors throughout the four-day event. The live event will be accessible on https:\/\/ir.lanternpharma.com\u00a0and will be archived for 90 days. Investors interested in scheduling a meeting with Mr. Sharma should contact their Needham &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Lantern Pharma to Participate in the Virtual 20th Annual Needham Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-471493","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lantern Pharma to Participate in the Virtual 20th Annual Needham Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lantern Pharma to Participate in the Virtual 20th Annual Needham Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire DALLAS, April 6, 2021 \/PRNewswire\/ &#8212;\u00a0Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR\u00ae artificial intelligence (&#8220;A.I.&#8221;) platform to transform oncology drug discovery and development today announced that Panna Sharma, President and CEO of Lantern Pharma, will participate in the 20th Annual Needham Healthcare Conference, to be held virtually on April 12-15, 2021. Mr. Sharma will participate in a fireside chat moderated by Needham &amp; Company&#8217;s Alexander Salisbury on Thursday, April 15, at 12:45 pm ET and hold one-on-one meetings with investors throughout the four-day event. The live event will be accessible on https:\/\/ir.lanternpharma.com\u00a0and will be archived for 90 days. Investors interested in scheduling a meeting with Mr. Sharma should contact their Needham &hellip; Continue reading &quot;Lantern Pharma to Participate in the Virtual 20th Annual Needham Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-06T11:48:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1216507\/Lantern_Pharma_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lantern Pharma to Participate in the Virtual 20th Annual Needham Healthcare Conference\",\"datePublished\":\"2021-04-06T11:48:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\\\/\"},\"wordCount\":831,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1216507\\\/Lantern_Pharma_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\\\/\",\"name\":\"Lantern Pharma to Participate in the Virtual 20th Annual Needham Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1216507\\\/Lantern_Pharma_Logo.jpg\",\"datePublished\":\"2021-04-06T11:48:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1216507\\\/Lantern_Pharma_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1216507\\\/Lantern_Pharma_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lantern Pharma to Participate in the Virtual 20th Annual Needham Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lantern Pharma to Participate in the Virtual 20th Annual Needham Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Lantern Pharma to Participate in the Virtual 20th Annual Needham Healthcare Conference - Market Newsdesk","og_description":"PR Newswire DALLAS, April 6, 2021 \/PRNewswire\/ &#8212;\u00a0Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR\u00ae artificial intelligence (&#8220;A.I.&#8221;) platform to transform oncology drug discovery and development today announced that Panna Sharma, President and CEO of Lantern Pharma, will participate in the 20th Annual Needham Healthcare Conference, to be held virtually on April 12-15, 2021. Mr. Sharma will participate in a fireside chat moderated by Needham &amp; Company&#8217;s Alexander Salisbury on Thursday, April 15, at 12:45 pm ET and hold one-on-one meetings with investors throughout the four-day event. The live event will be accessible on https:\/\/ir.lanternpharma.com\u00a0and will be archived for 90 days. Investors interested in scheduling a meeting with Mr. Sharma should contact their Needham &hellip; Continue reading \"Lantern Pharma to Participate in the Virtual 20th Annual Needham Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-06T11:48:22+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1216507\/Lantern_Pharma_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lantern Pharma to Participate in the Virtual 20th Annual Needham Healthcare Conference","datePublished":"2021-04-06T11:48:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\/"},"wordCount":831,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1216507\/Lantern_Pharma_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\/","name":"Lantern Pharma to Participate in the Virtual 20th Annual Needham Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1216507\/Lantern_Pharma_Logo.jpg","datePublished":"2021-04-06T11:48:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1216507\/Lantern_Pharma_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1216507\/Lantern_Pharma_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-to-participate-in-the-virtual-20th-annual-needham-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lantern Pharma to Participate in the Virtual 20th Annual Needham Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/471493","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=471493"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/471493\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=471493"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=471493"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=471493"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}